From October 1, 2023 to December 31, 2023, the company has repurchased 811,384 shares, representing 1.29% for $99.79 million. With this, the company has completed the repurchase of 9,991,026 shares, representing 16.77% for $1,358.79 million under the buyback announced on November 8, 2016.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
103.5 USD | -1.48% |
|
-3.39% | -15.83% |
07-01 | Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell 1000 Growth Index | CI |
07-01 | Jazz Pharmaceuticals plc(NasdaqGS:JAZZ) dropped from Russell Midcap Growth Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.83% | 6.53B | |
+54.07% | 809B | |
+39.24% | 621B | |
-7.05% | 351B | |
+15.44% | 319B | |
+5.72% | 289B | |
+14.72% | 238B | |
-0.70% | 221B | |
+14.53% | 218B | |
+7.42% | 166B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Tranche Update on Jazz Pharmaceuticals plc's Equity Buyback Plan announced on November 8, 2016.